Payout • Biomm
BIOM3
Biomm is a Brazilian biopharmaceutical company focused on the development, production and sale of biotech and biosimilar drugs in the domestic market. Its main therapeutic focus is treating diabetes, with a portfolio that includes human insulin and insulin analogs, such as glargine. The company's business model is based on strategic partnerships with international pharmaceutical companies to license and introduce new technologies and products in Brazil. A central pillar of its strategy is to build its own plant in Nova Lima (MG), which will allow local insulin production. Biomm markets its products both in the private market, through pharmacies, and in the public sector, through government tenders.
0
Dividend Per Share
The sum of declared dividends issued by a company for every ordinary share outstanding.
0%
Dividend Yield
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
0%
Dividend Yield 5Y
The average of the dividend yield over the last 60 months.
0%
Payout
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!